PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
6.41
-0.09 (-1.38%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close6.50
Open6.54
Bid6.22 x 300
Ask6.62 x 300
Day's Range6.29 - 6.54
52 Week Range4.60 - 11.72
Volume892,531
Avg. Volume1,103,247
Market Cap450.43M
Beta3.92
PE Ratio (TTM)-106.83
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PGNX-US : October 20, 2017
    Capital Cubeyesterday

    Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PGNX-US : October 20, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Progenics Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Have Investors Already Priced In Progenics Pharmaceuticals Inc’s (PGNX) Growth?
    Simply Wall St.9 days ago

    Have Investors Already Priced In Progenics Pharmaceuticals Inc’s (PGNX) Growth?

    Progenics Pharmaceuticals Inc (NASDAQ:PGNX), a biotechnology company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqGS. AsRead More...

  • Capital Cube16 days ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : October 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 3 Top Stocks in Healthcare
    Motley Fool24 days ago

    3 Top Stocks in Healthcare

    Find out why Align Technology, Mazor Robotics, and Progenics Pharmaceuticals are three of the best stocks in the red-hot healthcare sector right now.

  • Capital Cube26 days ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : September 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • What's Behind Progenics Pharmaceuticals, Inc.'s Bump Today?
    Motley Foollast month

    What's Behind Progenics Pharmaceuticals, Inc.'s Bump Today?

    A lack of significant news couldn't stop this biotech stock from surging today. Could this be why?

  • 3 Biotech Stocks I'd Buy Right Now
    Motley Foollast month

    3 Biotech Stocks I'd Buy Right Now

    The outlook for these underappreciated gems is much brighter than their recent performances suggest.

  • Capital Cubelast month

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cubelast month

    Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Progenics Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Progenics Pharmaceuticals, Inc. – Seattle Genetics, Inc., Nektar Therapeutics, Sucampo Pharmaceuticals, Inc. Class A, Synergy Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson and Ironwood Pharmaceuticals, Inc. ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : September 12, 2017
    Capital Cubelast month

    Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : September 12, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Progenics Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube2 months ago

    Progenics Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PGNX) : September 2, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Progenics Pharmaceuticals, Inc. a score of 82. Our analysis is based on comparing Progenics Pharmaceuticals, Inc. with the following peers – Seattle Genetics, Inc., Nektar Therapeutics, Sucampo Pharmaceuticals, Inc. Class A, Synergy Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson and Ironwood Pharmaceuticals, Inc. Class A ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : August 30, 2017
    Capital Cube2 months ago

    Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : August 30, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Progenics Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance?
    Capital Cube2 months ago

    Progenics Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance?

    Categories: Yahoo FinanceProgenics Pharmaceuticals, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 82. Our analysis is based on comparing Progenics Pharmaceuticals, Inc. with the following peers – Seattle Genetics, Inc., Nektar Therapeutics, Sucampo Pharmaceuticals, Inc. Class A, Synergy Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson and Ironwood Pharmaceuticals, Inc. Class ... Read more (Read more...)

  • 3 Beaten-Up Biotech Stocks: Are They Bargains?
    Motley Fool2 months ago

    3 Beaten-Up Biotech Stocks: Are They Bargains?

    It's been a pretty good year for biotech, but these three stocks have tumbled. Is the pessimism overblown?

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PGNX earnings conference call or presentation 9-Aug-17 12:30pm GMT

    Q2 2017 Progenics Pharmaceuticals Inc Earnings Call

  • Associated Press2 months ago

    Progenics reports 2Q loss

    The New York-based company said it had a loss of 24 cents per share. The biopharmaceutical company posted revenue of $2.8 million in the period. Progenics shares have decreased 30 percent since the beginning ...

  • Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today
    Motley Fool2 months ago

    Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today

    The market couldn't see past a precipitous drop in royalty revenue during the first quarter.

  • Capital Cube3 months ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : August 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : July 24, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Benzinga3 months ago

    Progenics Shares Could Double, According To Cantor

    Cantor Fitzgerald analyst Mara Goldstein initiated coverage on Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ) with an Overweight rating and $15 price target. The stock jumped 2.4 percent Wednesday to ...

  • Capital Cube4 months ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : June 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : June 22, 2017
    Capital Cube4 months ago

    Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : June 22, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Progenics Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Progenics Pharmaceuticals, Inc. : June 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Progenics Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube4 months ago

    Progenics Pharmaceuticals, Inc. :PGNX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Progenics Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Progenics Pharmaceuticals, Inc. – Seattle Genetics, Inc., Nektar Therapeutics, Sucampo Pharmaceuticals, Inc. Class A, Synergy Pharmaceuticals, Inc., Astrazeneca PLC Sponsored ADR, Johnson & Johnson and Ironwood Pharmaceuticals, Inc. ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of PGNX earnings conference call or presentation 4-May-17 12:30pm GMT

    Q1 2017 Progenics Pharmaceuticals Inc Earnings Call